DSIP (Delta Sleep-Inducing Peptide): A Research Overview

DSIP is one of the older and more intriguing research peptides — a naturally occurring molecule named for the very effect it was discovered producing. But its name is also a trap: “delta sleep-inducing peptide” sounds like a settled conclusion, while the actual literature, decades on, is notably mixed about how — or how reliably — it affects human sleep. An honest overview keeps the genuine history and the unresolved mechanism in clear view rather than letting the name do the talking.

This overview summarizes what the published literature reports about DSIP — its identity, proposed roles, the state of the evidence, and its status. It describes findings as they appeared in their study systems. It is not dosing guidance, medical advice, or a recommendation for use.

What DSIP Is

DSIP is a naturally occurring neuropeptide — a nonapeptide (nine amino acids) with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE), molecular weight about 849. It was discovered in 1974 by Schoeneberger and Monnier, isolated from the cerebral venous blood of rabbits whose sleep had been induced by thalamic stimulation (Schoenenberger & Monnier, original isolation & sequence (PubMed)). It is found endogenously in the hypothalamus, limbic system, pituitary, and peripheral organs, and is unusual among peptides in that it can cross the blood–brain barrier and is reasonably stable to gut enzymes (blood–brain-barrier crossing and distribution).

Proposed Roles and Mechanisms

DSIP was named for its ability to induce delta-wave (deep, slow-wave) sleep in early animal studies, and beyond sleep, it has been associated in research with stress-protective, anti-seizure, and immunomodulatory effects, as well as influences on neurotransmitter levels, circadian patterns, and hormonal secretion (multifunctional roles review). Crucially, however, the mechanism is not established: the precise way DSIP would promote sleep “remains unknown,” and its half-life is very short (around 15 minutes) (Schoenenberger, characterization (Eur Neurol 1984, PMID 6548966)).

The Evidence Base — Mixed and Inconclusive

This is the part the name obscures, and it deserves emphasis. While DSIP induced slow-wave sleep in some animal studies, not all preclinical studies reproduced the effect, and the human sleep evidence is thin: it is reported that only one study examined DSIP’s effect on sleep EEG in normal men, and it found only minor effects (non-reproduction in some studies; minimal human EEG effect). Some older human and animal studies reported stress-protective and relaxation effects, but the overall body of evidence is dated, mixed, and inconclusive, rather than providing a clear demonstration of a reliable sleep effect in humans.

• Naturally occurring nonapeptide (WAGGDASGE); crosses the blood–brain barrier; short half-life (~15 min).
• Named for delta-sleep induction, but the mechanism is unknown, and not all studies reproduce the sleep effect.
• Evidence for human sleep is minimal; the overall record is mixed and inconclusive, not definitive.

Regulatory Status

The status below reflects mid-2026 and may change; verify before relying on it. DSIP is not FDA-approved for any indication. It is sold as a research-grade compound for laboratory use only and, by its labeling, is not for human consumption. It has not been developed into an approved sleep therapy in the decades since its discovery — a fact that itself reflects the unsettled state of the evidence.

Why DSIP Draws Research Interest

DSIP is of genuine scientific interest as an endogenous, blood–brain-barrier-crossing neuropeptide implicated in sleep, stress adaptation, and neuroendocrine regulation — a useful probe of those systems. The accurate framing is a naturally occurring peptide with a long research history, an unestablished mechanism, a mixed and largely inconclusive evidence base (especially in humans), and no regulatory approval. Intriguing and well-studied historically, but far from a proven sleep agent.

For deeper reading, the cited literature is the best starting point. The wider class of research peptides is collected in our peptide research library.